Pembrolizumab in RCC & Evolving Role of Immunotherapy in Metastatic RCC: ASCO 2018
By
Beacon Medical Interchange
FEATURING
Daniel Goldstein
By
Beacon Medical Interchange
FEATURING
Daniel Goldstein
Dr. Daniel Goldstein discusses the results of a trial of first line pembrolizumab (Keytruda) as ...
read more ↘
read more ↘
Comments 0
Login to view comments.
Click here to Login
